Src family kinases, adaptor proteins and the actin cytoskeleton in epithelial-to-mesenchymal transition

MA Ortiz, T Mikhailova, X Li, BA Porter, A Bah… - Cell Communication and …, 2021 - Springer
Over a century of scientific inquiry since the discovery of v-SRC but still no final judgement
on SRC function. However, a significant body of work has defined Src family kinases as key …

Multi‐Enzyme Co‐Expressed Nanomedicine for Anti‐Metastasis Tumor Therapy by Up‐Regulating Cellular Oxidative Stress and Depleting Cholesterol

Y Liu, R Niu, R Deng, Y Wang, S Song… - Advanced …, 2024 - Wiley Online Library
Tumor cells movement and migration are inseparable from the integrity of lipid rafts and the
formation of lamellipodia, and lipid rafts are also a prerequisite for the formation of …

Combinatorial nanocarriers against drug resistance in hematological cancers: opportunities and emerging strategies

S Ghosh, R Lalani, V Patel, D Bardoliwala… - Journal of Controlled …, 2019 - Elsevier
Hematological cancers are a group of malignancies affecting human hematopoietic and
lymphoid tissues. Although the patients respond to treatment regimen during initial phases …

Single-cell lymphocyte heterogeneity in advanced cutaneous T-cell lymphoma skin tumors

AM Gaydosik, T Tabib, LJ Geskin, CA Bayan… - Clinical Cancer …, 2019 - AACR
Purpose: The heterogeneity of tumor cells presents a major challenge to cancer diagnosis
and therapy. Cutaneous T-cell lymphomas (CTCL) are a group of T lymphocyte …

Cancer-associated fibroblast-derived exosomal miR-18b promotes breast cancer invasion and metastasis by regulating TCEAL7

Z Yan, Z Sheng, Y Zheng, R Feng, Q Xiao, L Shi… - Cell Death & …, 2021 - nature.com
Studies have shown that cancer-associated fibroblasts (CAFs) play an irreplaceable role in
the occurrence and development of tumors. Therefore, exploring the action and mechanism …

Acute myeloid leukemia (AML)‐derived mesenchymal stem cells induce chemoresistance and epithelial–mesenchymal transition‐like program in AML through IL‐6 …

J Lu, Q Dong, S Zhang, Y Feng, J Yang… - Cancer …, 2023 - Wiley Online Library
Acute myeloid leukemia (AML) has a high rate of treatment failure due to increased
prevalence of therapy resistance. Mesenchymal stem cells (MSCs) in the leukemia …

Fabrication of a three-dimensional bone marrow niche-like acute myeloid Leukemia disease model by an automated and controlled process using a robotic …

DM Alhattab, I Isaioglou, S Alshehri, ZN Khan… - Biomaterials …, 2023 - spj.science.org
Background Acute myeloid leukemia (AML) is a hematological malignancy that remains a
therapeutic challenge due to the high incidence of disease relapse. To better understand …

Curcumin inhibited the growth and invasion of human monocytic leukaemia SHI-1 cells in vivo by altering MAPK and MMP signalling

G Zhu, Q Shen, H Jiang, O Ji, L Zhu… - Pharmaceutical …, 2020 - Taylor & Francis
Context Curcumin, a polyphenolic compound extracted from the rhizome of the tropical plant
Curcuma longa L.(Zingiberaceae), has been considered as a cancer chemopreventive drug …

Expression profiling of extramedullary acute myeloid leukemia suggests involvement of epithelial–mesenchymal transition pathways

T Ottone, G Silvestrini, R Piazza, S Travaglini… - Leukemia, 2023 - nature.com
Extramedullary (EM) colonization is a rare complication of acute myeloid leukemia (AML),
occurring in about 10% of patients, but the processes underlying tissue invasion are not …

Leukemic stem cell: a mini-review on clinical perspectives

IV Barreto, FMCP Pessoa, CB Machado… - Frontiers in …, 2022 - frontiersin.org
Hematopoietic stem cells (HSCs) are known for their ability to proliferate and self-renew,
thus being responsible for sustaining the hematopoietic system and residing in the bone …